IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating …
$0.20+5.82%
报价 2026-11-06
市值
$20.7M
EV
$31.6M
PE (TTM)
–
预期 PE (FY2027)
–
52 周区间距高点 -48.3%
$0.19$0.39
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| IGCIGC Pharma, Inc. | $20.7M | +5.8% | +25.0% | 21.9% | – | – | – | |
| SABSSAB Biotherapeutics, Inc. | $275.7M | +3.1% | +50.0% | 0% | 0.9x | – | – | |
| QTTBQ32 Bio Inc. | $275.4M | +4.5% | 0.0% | 99.8% | 3.1x | 4.5x | – | |
| ANTXAN2 Therapeutics, Inc. | $150.9M | +1.1% | +119.0% | 0% | – | – | – | |
| NTRBNutriband Inc. | $67.5M | -0.4% | +3433.3% | 33.1% | – | – | – | |
| BOLDBoundless Bio, Inc. | $56M | +2.1% | – | 0% | – | – | – | |
| NXTCNextCure, Inc. | $24.4M | +4.1% | -85.2% | 0% | – | – | – | |
| PLURPluri Inc. | $13.3M | +3.8% | – | 44.6% | – | – | – | |
| INTSIntensity Therapeutics, Inc. | $8.1M | -3.2% | – | 0% | – | – | – | |
| 同行中位数 | – | – | +50.0% | 0% | 2.0x | 4.5x | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。